mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |